Home - Products - Others - Other Targets - 4-((2-ethylidene-4-hydroxy-6-methylhept-5-en-1-yl)oxy)-bergaptol

4-((2-ethylidene-4-hydroxy-6-methylhept-5-en-1-yl)oxy)-bergaptol

CAS No. ———

4-((2-ethylidene-4-hydroxy-6-methylhept-5-en-1-yl)oxy)-bergaptol( ——— )

Catalog No. M38655 CAS No. ———

4-((2-ethylidene-4-hydroxy-6-methylhept-5-en-1-yl)oxy)-bergaptol

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    4-((2-ethylidene-4-hydroxy-6-methylhept-5-en-1-yl)oxy)-bergaptol
  • Note
    Research use only, not for human use.
  • Brief Description
    4-((2-ethylidene-4-hydroxy-6-methylhept-5-en-1-yl)oxy)-bergaptol
  • Description
    4-((2-ethylidene-4-hydroxy-6-methylhept-5-en-1-yl)oxy)-bergaptol
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Zinc bacitracin

    Bacitracin Zinc is a dephosphorylation of the C55-isoprenyl pyrophosphate interference for inhibition of cleavage of Tyr from Met-enkephalin with IC50 of 10 μM.

  • Erythro -Guaiacylgly...

    Erythro-guaiacylglycerol-β-ferulic acid ether is a natural product that can be isolated from Gueldenstaedtia verna.

  • CAY10781

    CAY10781 is an inhibitor of the protein-protein interaction between neuropilin-1 (NRP-1) and VEGF-A.1It inhibits the interaction by 43% when used at a concentration of 12.5 μM. CAY10781 also inhibits VEGF-A-induced phosphorylation of VEGFR2 in catecholamine A-differentiated (CAD) cells when used at the same concentration.